Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Merial’s Circovac PCV2 licensed for use among piglets

Merial’s Circovac PCV2 licensed for use among piglets

14th February 2011

Merial Animal Health has announced that its type 2 porcine circovirus (PCV2) vaccine Circovac has been approved for use among piglets.

The treatment, the first PCV2 vaccine available globally, received a licence to be used in sows in June 2007 and is now the only product of its kind approved for use among the whole herd.

Field studies involving the drug have shown that its performance levels are comparable to other vaccines for piglets, but its added flexibility and breadth of coverage make it economically beneficial.

The new Circovac specification gives farmers another means of combating PCV2, which is estimated to cost the European pig industry around 468 million pounds a year.

Ricardo Neto, Merial's veterinary advisor, said: "No matter what regime they choose, Circovac now provides a cost-effective whole herd solution that will help them to increase their profitability."

Last month, the company entered into a new collaboration with GenVec that will see the companies developing new foot-and-mouth disease vaccines.ADNFCR-8000103-ID-800403751-ADNFCR

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.